Contract manufacturing giant Catalent has announced its plan to buy gummy vitamins maker Bettera Holdings for $1 billion in cash, in a bid to expand in the nutritional supplements market.
Texas-based Bettera, backed by private investment firm Highlander Partners, makes vitamins, supplements and minerals delivered in the form of gummies, lozenges and chewables. Bettera has four production facilities in the U.S. and according to a Catalent press release, offers "difficult-to-replicate expertise in successfully developing and producing consumer-preferred products for nutraceutical, functional and botanical ingredients."
Catalent — which has also been tapped to make Moderna, AstraZeneca and J&J vaccines — currently makes softgel capsules as part of its global softgel and oral dose formulation and manufacturing business. The buy will enable the CDMO to expand its current consumer health technology platform into the surging gummy and soft-chew sector.
The acquisition is expected to close before the end of 2021, and includes the transfer of substantially all of the approximately 500 employees, and product development, manufacturing, and packaging assets of Bettera Holdings, including its production facilities in California, Indiana, New Jersey and Virginia
